Yale Cancer Center and Smilow Cancer Hospital received a two year, $750,000 grant from Genentech, a member of the Roche Group, to measure, address, and create accountability around cancer health inequities.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe